Ayşegül Sarı

681 total citations
54 papers, 430 citations indexed

About

Ayşegül Sarı is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Ayşegül Sarı has authored 54 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Ayşegül Sarı's work include Peptidase Inhibition and Analysis (6 papers), Breast Lesions and Carcinomas (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Ayşegül Sarı is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Breast Lesions and Carcinomas (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Ayşegül Sarı collaborates with scholars based in Türkiye, United States and Canada. Ayşegül Sarı's co-authors include Türkan Rezanko, Aylin Örgen Çallı, Fulya Çakalağaoğlu, Seyran Yiğit, Yüksel Küçükzeybek, Mustafa Oktay Tarhan, Alper Can, Çiğdem Erten, İbrahim Vedat Bayoğlu and Lütfiye Demir and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Ayşegül Sarı

54 papers receiving 421 citations

Peers

Ayşegül Sarı

ONCOL

SURGE

EPIDE

PRM

Elisabetta Froio Italy

H. Jouhadi Morocco

Anjum Hassan United States

Bhuvana A. Setty United States

Laura Ardighieri Italy

T. Geldart United Kingdom

Kathrin Glatz Switzerland

Pamela Sighinolfi Italy

Andres Quesada United States

Yoshiko Sudo Japan

Elisabetta Froio Italy

Ayşegül Sarı

189 ×1.1

ONCOL

83 ×0.8

SURGE

56 ×0.6

149 ×1.8

EPIDE

88 ×1.1

PRM

Citations per year, relative to Ayşegül Sarı Ayşegül Sarı (= 1×) peers Elisabetta Froio

Countries citing papers authored by Ayşegül Sarı

Since Specialization

Citations

This map shows the geographic impact of Ayşegül Sarı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşegül Sarı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşegül Sarı more than expected).

Fields of papers citing papers by Ayşegül Sarı

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşegül Sarı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşegül Sarı. The network helps show where Ayşegül Sarı may publish in the future.

Co-authorship network of co-authors of Ayşegül Sarı

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşegül Sarı. A scholar is included among the top collaborators of Ayşegül Sarı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşegül Sarı. Ayşegül Sarı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoeijmakers, Lianne, Marta López‐Yurda, Lindsay G. Grijpink-Ongering, et al.. (2023). 1112P Five-year survival after intermittent targeted therapy and anti-PD1 in stage IV melanoma: An update of the IMPemBra trial. Annals of Oncology. 34. S670–S670. 1 indexed citations

Cyr, David P., Kai Duan, Ayşegül Sarı, et al.. (2022). A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer. The American Journal of Surgical Pathology. 46(10). 1340–1351. 11 indexed citations

Sarı, Ayşegül, et al.. (2021). Clinicopathological analysis of invasive cribriform carcinoma of the breast, with review of the literature. Annals of Diagnostic Pathology. 54. 151794–151794. 5 indexed citations

Coşkun, Mehmet, et al.. (2020). The role of rare breast cancers in the false negative strain elastography results. La radiologia medica. 126(3). 349–355. 6 indexed citations

Bayoğlu, İbrahim Vedat, Yüksel Küçükzeybek, Ahmet Alacacıoğlu, et al.. (2019). The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer.. PubMed. 22(4). 947–952. 1 indexed citations

Sikorska, Karolina, Lindsay G. Grijpink-Ongering, Bart A. van de Wiel, et al.. (2018). Phase II study comparing pembrolizumab (PEM) with intermittent/short‐term dual MAPK pathway inhibition plus PEM in patients harboring the BRAFV600 mutation (IMPemBra). Annals of Oncology. 29. viii736–viii736. 7 indexed citations

Çallı, Aylin Örgen, et al.. (2017). The Histopathological Parameters Affecting Biochemical Recurrence in Radical Prostatectomies.. PubMed. 27(4). 213–217. 3 indexed citations

Acar, Turan, Ercüment Tarcan, Mehmet Hacıyanlı, et al.. (2015). How to approach phyllodes tumors of the breast?. Turkish Journal of Surgery. 31(4). 197–201. 8 indexed citations

Sarı, Ayşegül, et al.. (2015). Cytopathological features of matrix-producing carcinoma of the breast. Journal of Cytology. 32(1). 33–33. 2 indexed citations

10.

Neşe, Nalan, Banu Sarsık, Dilek Ertoy Baydar, et al.. (2015). Small Cell Carcinomas of the Bladder Highly Express Somatostatin Receptor Type 2A. Applied immunohistochemistry & molecular morphology. 24(4). 253–260. 4 indexed citations

11.

Demir, Lütfiye, Seyran Yiğit, Hülya Ellıdokuz, et al.. (2013). Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clinical & Experimental Metastasis. 30(8). 1047–1062. 50 indexed citations

12.

Sarı, Ayşegül, et al.. (2012). Mast cells positive for cluster of differentiation 117 protein: are they players or conductor in the orchestra of cholesteatoma?. The Journal of Laryngology & Otology. 126(8). 775–779. 1 indexed citations

13.

Rezanko, Türkan, et al.. (2011). Epithelioid schwannoma of soft tissue: unusual morphological variant causing a diagnostic dilemma. Annals of Diagnostic Pathology. 16(6). 521–526. 11 indexed citations

14.

Sarı, Ayşegül, et al.. (2011). Inflammatory Pseudotumor of the Breast. The Breast Journal. 17(3). 312–314. 11 indexed citations

15.

Sarı, Ayşegül, et al.. (2011). Association of mast cells with microvessel density in urothelial carcinomas of the urinary bladder. Annals of Diagnostic Pathology. 16(1). 1–6. 14 indexed citations

16.

Sarı, Ayşegül, Aylin Örgen Çallı, Sacit Nuri Görgel, et al.. (2011). Immunohistochemical Determination of ETS-1 Oncoprotein Expression in Urothelial Carcinomas of the Urinary Bladder. Applied immunohistochemistry & molecular morphology. 20(2). 153–158. 5 indexed citations

17.

Sarı, Ayşegül, et al.. (2011). Sarcomatoid chromophobe renal cell carcinoma with osteosarcoma-like differentiation which presented as a retroperitoneal mass: a case report. Turkish Journal of Pathology. 27(2). 164–164. 2 indexed citations

18.

Sarı, Ayşegül, et al.. (2010). Papillary renal cell carcinoma with lipocyte-like cells: A rare morphological variant or an indication of aggressiveness?. Indian Journal of Pathology and Microbiology. 53(3). 541–541. 1 indexed citations

19.

Rezanko, Türkan, et al.. (2008). Is it possible to start the treatment based on immediate cytologic evaluation of core needle biopsy of the spinal lesions?. Diagnostic Cytopathology. 36(7). 478–484. 7 indexed citations

20.

Sarı, Ayşegül, et al.. (2007). Lipofibromatosis in a two-year-old girl: a case report.. SHILAP Revista de lepidopterología. 49(3). 319–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact